Serotonin releasing agent
Serotonin releasing agents (SRAs) are a type of drug that induces the release of serotonin into the neuronal synapse. They are commonly used in the treatment of various conditions, including depression, anxiety, and obesity.
Mechanism of Action[edit | edit source]
SRAs work by increasing the amount of serotonin in the brain. They do this by binding to the serotonin transporter (SERT), which is responsible for the reuptake of serotonin back into the neuron. By blocking this reuptake, SRAs allow more serotonin to be available in the synapse, leading to increased serotonergic activity.
Types of Serotonin Releasing Agents[edit | edit source]
There are several different types of SRAs, including:
- Amphetamines: These drugs, such as dextroamphetamine and methamphetamine, are potent SRAs. They are often used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy.
- MDMA: Also known as ecstasy, this drug is a potent SRA and is often used recreationally. It has also been investigated for its potential use in the treatment of post-traumatic stress disorder (PTSD).
- Fenfluramine: This drug was once used as an appetite suppressant in the treatment of obesity, but was withdrawn from the market due to concerns about heart valve disease.
Side Effects[edit | edit source]
The use of SRAs can lead to a number of side effects, including:
- Serotonin syndrome: This is a potentially life-threatening condition that can occur with excessive serotonergic activity. Symptoms can include agitation, restlessness, confusion, rapid heart rate, dilated pupils, loss of muscle coordination, heavy sweating, diarrhea, headache, shivering, and goosebumps.
- Neurotoxicity: Some SRAs, such as MDMA, have been associated with neurotoxic effects, potentially leading to long-term damage to serotonin neurons.
- Dependence and withdrawal: Some SRAs, particularly amphetamines, can lead to physical dependence and withdrawal symptoms when the drug is discontinued.
See Also[edit | edit source]
- Serotonin-norepinephrine reuptake inhibitors
- Selective serotonin reuptake inhibitors
- Serotonin antagonist and reuptake inhibitors
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
